504 related articles for article (PubMed ID: 7952881)
1. Characterization of the angiotensin II AT1 receptor subtype involved in DNA synthesis in cultured vascular smooth muscle cells.
Briand V; Riva L; Galzin AM
Br J Pharmacol; 1994 Aug; 112(4):1195-201. PubMed ID: 7952881
[TBL] [Abstract][Full Text] [Related]
2. Differential regulation of prostaglandin synthesis by angiotensin peptides in porcine aortic smooth muscle cells: subtypes of angiotensin receptors involved.
Jaiswal N; Tallant EA; Jaiswal RK; Diz DI; Ferrario CM
J Pharmacol Exp Ther; 1993 May; 265(2):664-73. PubMed ID: 8496814
[TBL] [Abstract][Full Text] [Related]
3. In vitro and in vivo effects of UP 269-6, a new potent orally active nonpeptide angiotensin II receptor antagonist, on vascular smooth muscle cell proliferation.
Virone-Oddos A; Desangle V; Provost D; Cazes M; Caussade F; Cloarec A
Br J Pharmacol; 1997 Feb; 120(3):488-94. PubMed ID: 9031754
[TBL] [Abstract][Full Text] [Related]
4. The angiotensin AT2-receptor mediates inhibition of cell proliferation in coronary endothelial cells.
Stoll M; Steckelings UM; Paul M; Bottari SP; Metzger R; Unger T
J Clin Invest; 1995 Feb; 95(2):651-7. PubMed ID: 7860748
[TBL] [Abstract][Full Text] [Related]
5. Effects of TH-142177 on angiotensin II-induced proliferation, migration and intracellular signaling in vascular smooth muscle cells and on neointimal thickening after balloon injury.
Nozawa Y; Matsuura N; Miyake H; Yamada S; Kimura R
Life Sci; 1999; 64(22):2061-70. PubMed ID: 10374931
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin II regulates vascular smooth muscle cell pH, contraction, and growth via tyrosine kinase-dependent signaling pathways.
Touyz RM; Schiffrin EL
Hypertension; 1997 Aug; 30(2 Pt 1):222-9. PubMed ID: 9260984
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin-(1-7) inhibits vascular smooth muscle cell growth.
Freeman EJ; Chisolm GM; Ferrario CM; Tallant EA
Hypertension; 1996 Jul; 28(1):104-8. PubMed ID: 8675248
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin II and insulin induce growth of ciliary artery smooth muscle: effects of AT1/AT2 antagonists.
Dubey RK; Flammer J; Lüscher TF
Invest Ophthalmol Vis Sci; 1998 Oct; 39(11):2067-75. PubMed ID: 9761285
[TBL] [Abstract][Full Text] [Related]
9. Characterization of renal angiotensin II receptors using subtype selective antagonists.
Edwards RM; Stack EJ; Weidley EF; Aiyar N; Keenan RM; Hill DT; Weinstock J
J Pharmacol Exp Ther; 1992 Mar; 260(3):933-8. PubMed ID: 1545405
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin II receptor subtypes and contractile responses in portal vein smooth muscle.
Pelet C; Mironneau C; Rakotoarisoa L; Neuilly G
Eur J Pharmacol; 1995 Jun; 279(1):15-24. PubMed ID: 7556378
[TBL] [Abstract][Full Text] [Related]
11. Effects of des-aspartate-angiotensin I on angiotensin II-induced incorporation of phenylalanine and thymidine in cultured rat cardiomyocytes and aortic smooth muscle cells.
Min L; Sim MK; Xu XG
Regul Pept; 2000 Nov; 95(1-3):93-7. PubMed ID: 11062338
[TBL] [Abstract][Full Text] [Related]
12. Effects of BAY 10-6734 (Embusartan), a new angiotensin II type I receptor antagonist, on vascular smooth muscle cell growth.
Iouzalen L; Stepien O; Marche P
J Pharmacol Exp Ther; 1999 Apr; 289(1):181-7. PubMed ID: 10087002
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological profile of GR117289 in vitro: a novel, potent and specific non-peptide angiotensin AT1 receptor antagonist.
Robertson MJ; Barnes JC; Drew GM; Clark KL; Marshall FH; Michel A; Middlemiss D; Ross BC; Scopes D; Dowle MD
Br J Pharmacol; 1992 Dec; 107(4):1173-80. PubMed ID: 1467838
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin type 1 receptors mediate smooth muscle proliferation and endothelin biosynthesis in rat vascular smooth muscle.
Sung CP; Arleth AJ; Storer BL; Ohlstein EH
J Pharmacol Exp Ther; 1994 Oct; 271(1):429-37. PubMed ID: 7965744
[TBL] [Abstract][Full Text] [Related]
15. CV-11974, the active metabolite of TCV-116 (Candesarten), inhibits the synergistic or additive effect of different growth factors on angiotensin II-induced proliferation of vascular smooth muscle cells.
Sachinidis A; el-Haschimi K; Ko Y; Seul C; Düsing R; Vetter H
Biochem Pharmacol; 1996 Jul; 52(1):123-6. PubMed ID: 8678895
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin II-elicited signal transduction via AT1 receptors in endothelial cells.
Pueyo ME; N'Diaye N; Michel JB
Br J Pharmacol; 1996 May; 118(1):79-84. PubMed ID: 8733579
[TBL] [Abstract][Full Text] [Related]
17. Vascular smooth-muscle cells contain AT1 angiotensin receptors coupled to phospholipase D activation.
Freeman EJ; Tallant EA
Biochem J; 1994 Dec; 304 ( Pt 2)(Pt 2):543-8. PubMed ID: 7998990
[TBL] [Abstract][Full Text] [Related]
18. AT1 receptors mediate the release of prostaglandins in porcine smooth muscle cells and rat astrocytes.
Leung KH; Chang RS; Lotti VJ; Roscoe WA; Smith RD; Timmermans PB; Chiu AT
Am J Hypertens; 1992 Sep; 5(9):648-56. PubMed ID: 1418854
[TBL] [Abstract][Full Text] [Related]
19. BMS-180560, an insurmountable inhibitor of angiotensin II-stimulated responses: comparison with losartan and EXP3174.
Dickinson KE; Cohen RB; Skwish S; Delaney CL; Serafino RP; Poss MA; Gu Z; Ryono DE; Moreland S; Powell JR
Br J Pharmacol; 1994 Sep; 113(1):179-89. PubMed ID: 7812609
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin II stimulates DNA and protein synthesis in vascular smooth muscle cells from human arteries: role of extracellular signal-regulated kinases.
Touyz RM; Deng LY; He G; Wu XH; Schiffrin EL
J Hypertens; 1999 Jul; 17(7):907-16. PubMed ID: 10419063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
